1. Adoption of the definition of probiotics as ‘Live microorganisms which when
administered in adequate amounts confer a health benefit on the host’.
2. Use and adoption of the guidelines in this report should be a prerequisite for
calling a bacterial strain ‘probiotic’.
3. Regulatory framework to allow specific health claims on probiotic food labels, in
cases where scientific evidence exists, as per the guidelines set forth in this report.
4. Promotion of these guidelines at an international level.
5. Good manufacturing practices (GMP) must be applied in the manufacture of
probiotic foods with quality assurance, and shelf-life conditions established.
6. Further development of methods (in vitro and in vivo) to evaluate the functionality
and safety of probiotics.